The Involvement of High Succinylation Modification in the Development of Prostate Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Nov 17

PMID 36387072

Authors

Zhenyang Zhang

Yanru Chen

Lingyu Fang

Jiang Zhao

Shishan Deng

Affiliations

Soon will be listed here.

Abstract

Objective: Succinylation modification of the lysine site plays an important role in tumorigenesis and development, but it is rarely reported in prostate cancer (PCa), so this study aims to elucidate its expression in and clinical correlation with PCa.

Methods: A total of 95 tumor, 3 normal and 52 paired adjacent tissue of PCa were involved for succinylation stanning. 498 PCa samples with 20 succinylation modification-related genes from TCGA were downloaded for model construction. Statistical methods were employed to analyze the data, including Non-Negative Matrix Factorization (NMF) algorithm, t-Distributed Stochastic Neighbor Embedding (t-SNE) algorithm and Cox regression analysis.

Results: The pan-succinyllysine antibody stanning indicated that tumor tissues showed higher succinyllysine level than adjacent tissues (p<0.001). Gleason grade and PDL1 expression levels were significantly different (p<0.001) among the high, medium and low succinylation staining scores. The types of PCa tissue were divided into four clusters using RNA-seq data of 20 succinylation-related genes in TCGA database. Clinical characterize of age, PSA level, and pathological stage showed differences among four clusters. The expression of succinylation-related genes (KAT5, SDHD and GLYATL1) and PCa related genes (PDL1, AR and TP53) were significantly different in 52 matched tumor and adjacent tissues (p<0.001). GLYATL1 and AR gene expression was significantly related to the pathological stage of PCa.

Conclusion: Succinylation was significantly increased in PCa tissues and was closely related to Gleason grade and PD-L1 expression. Model construction of 20 genes related to succinylation modification showed that the later the pathological stage of PCa, the higher the level of succinylation modification.

Citing Articles

Unlocking the Hidden Potential of Cancer Therapy Targeting Lysine Succinylation.

Zheng Z, Xiao P, Kuang J, Wang Z, Wang X, Huang D J Cancer. 2025; 16(3):821-834.

PMID: 39781339 PMC: 11705062. DOI: 10.7150/jca.105849.

Identification and validation of glucose metabolism-related gene signature in endometrial cancer.

Jiang J, Xia N, Yang M, Qiu P, Zhu W, Chen J BMC Cancer. 2025; 25(1):30.

PMID: 39773448 PMC: 11708096. DOI: 10.1186/s12885-024-13418-9.

Succinylation modification-mediated upregulation of Sp1 promotes hepatocellular carcinoma cell proliferation.

Han Y, Deng X, Chen H, Chen J, Xu W, Liu L Discov Oncol. 2024; 15(1):660.

PMID: 39548054 PMC: 11568111. DOI: 10.1007/s12672-024-01533-9.

Downregulation of GLYAT correlates with tumour progression and poor prognosis in hepatocellular carcinoma.

Jiang F, Zhou S, Xia C, Lu J, Wang B, Wang X J Cell Mol Med. 2024; 28(21):e70197.

PMID: 39495775 PMC: 11534071. DOI: 10.1111/jcmm.70197.

The role of protein post-translational modifications in prostate cancer.

Hao Y, Gu C, Luo W, Shen J, Xie F, Zhao Y PeerJ. 2024; 12:e17768.

PMID: 39148683 PMC: 11326433. DOI: 10.7717/peerj.17768.

References

Mu R, Ma Z, Lu C, Wang H, Cheng X, Tuo B . Role of succinylation modification in thyroid cancer and breast cancer. Am J Cancer Res. 2021; 11(10):4683-4699. PMC: 8569371. View

Gao Y, Nihira N, Bu X, Chu C, Zhang J, Kolodziejczyk A . Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy. Nat Cell Biol. 2020; 22(9):1064-1075. PMC: 7484128. DOI: 10.1038/s41556-020-0562-4. View

Beltran L, Ahmad A, Sandu H, Kudahetti S, Soosay G, Moller H . Histopathologic False-positive Diagnoses of Prostate Cancer in the Age of Immunohistochemistry. Am J Surg Pathol. 2018; 43(3):361-368. PMC: 6375390. DOI: 10.1097/PAS.0000000000001202. View

Ai L, Xu A, Xu J . Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond. Adv Exp Med Biol. 2020; 1248:33-59. DOI: 10.1007/978-981-15-3266-5_3. View

Mao M, Xue Y, He Y, Zhou X, Rafique F, Hu H . Systematic identification and comparative analysis of lysine succinylation between the green and white parts of chimeric leaves of Ananas comosus var. bracteatus. BMC Genomics. 2020; 21(1):383. PMC: 7268518. DOI: 10.1186/s12864-020-6750-6. View

Bruno S, Falagario U, dAltilia N, Recchia M, Mancini V, Selvaggio O . PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study. Front Oncol. 2021; 11:693684. PMC: 8173030. DOI: 10.3389/fonc.2021.693684. View

Costello A . Considering the role of radical prostatectomy in 21st century prostate cancer care. Nat Rev Urol. 2020; 17(3):177-188. DOI: 10.1038/s41585-020-0287-y. View

Nalla A, Williams T, Collins C, Rae D, Trobridge G . Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome. Mol Carcinog. 2015; 55(11):1761-1771. PMC: 5393267. DOI: 10.1002/mc.22425. View

Srigley J, Delahunt B, Samaratunga H, Billis A, Cheng L, Clouston D . Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation. Pathology. 2019; 51(5):463-473. DOI: 10.1016/j.pathol.2019.05.001. View

10.

Kim T, Lee Y, Koo K . Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review. Biomolecules. 2021; 11(4). PMC: 8064397. DOI: 10.3390/biom11040492. View

11.

Routtenberg A, Rekart J . Post-translational protein modification as the substrate for long-lasting memory. Trends Neurosci. 2005; 28(1):12-9. DOI: 10.1016/j.tins.2004.11.006. View

12.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

13.

Kwon O, Bang I, Choi S, Jeon J, Na A, Gao Y . LDHA Desuccinylase Sirtuin 5 as A Novel Cancer Metastatic Stimulator in Aggressive Prostate Cancer. Genomics Proteomics Bioinformatics. 2022; 21(1):177-189. PMC: 10372916. DOI: 10.1016/j.gpb.2022.02.004. View

14.

Busetto G, Del Giudice F, Maggi M, De Marco F, Porreca A, Sperduti I . Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy. World J Urol. 2020; 39(6):1869-1877. PMC: 8217060. DOI: 10.1007/s00345-020-03359-w. View

15.

Xu Y, Song G, Xie S, Jiang W, Chen X, Chu M . The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer. Mol Ther. 2021; 29(6):1958-1969. PMC: 8178461. DOI: 10.1016/j.ymthe.2021.04.029. View

16.

Matsuo M, Terai K, Kameda N, Matsumoto A, Kurokawa Y, Funase Y . Designation of enzyme activity of glycine-N-acyltransferase family genes and depression of glycine-N-acyltransferase in human hepatocellular carcinoma. Biochem Biophys Res Commun. 2012; 420(4):901-6. DOI: 10.1016/j.bbrc.2012.03.099. View

17.

Guan R, Hong W, Huang J, Peng T, Zhao Z, Lin Y . The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma. J Gastrointest Oncol. 2021; 11(6):1305-1321. PMC: 7807277. DOI: 10.21037/jgo-20-186. View

18.

Velho P, Antonarakis E . PD-1/PD-L1 pathway inhibitors in advanced prostate cancer. Expert Rev Clin Pharmacol. 2018; 11(5):475-486. PMC: 6317331. DOI: 10.1080/17512433.2018.1464388. View

19.

McAllister M, Underwood M, Leung H, Edwards J . A review on the interactions between the tumor microenvironment and androgen receptor signaling in prostate cancer. Transl Res. 2018; 206:91-106. DOI: 10.1016/j.trsl.2018.11.004. View

20.

Sciarra A, Maggi M, Salciccia S, Nicolai A, Tortorella E, Giantulli S . Tissue Expression of Androgen Receptor Splice Variant 7 at Radical Prostatectomy Predicts Risk of Progression in Untreated Nonmetastatic Prostate Cancer. Oncology. 2021; 99(4):251-255. DOI: 10.1159/000512445. View